176 related articles for article (PubMed ID: 9069478)
41. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.
Brooks DJ; Ibanez V; Sawle GV; Playford ED; Quinn N; Mathias CJ; Lees AJ; Marsden CD; Bannister R; Frackowiak RS
Ann Neurol; 1992 Feb; 31(2):184-92. PubMed ID: 1575457
[TBL] [Abstract][Full Text] [Related]
42. Proton magnetic resonance spectroscopy of the lenticular nuclei in bipolar I affective disorder.
Ohara K; Isoda H; Suzuki Y; Takehara Y; Ochiai M; Takeda H; Igarashi Y; Ohara K
Psychiatry Res; 1998 Dec; 84(2-3):55-60. PubMed ID: 10710163
[TBL] [Abstract][Full Text] [Related]
43. Dorsolateral prefrontal cortex N-acetylaspartate/total creatine (NAA/tCr) loss in male recreational cannabis users.
Hermann D; Sartorius A; Welzel H; Walter S; Skopp G; Ende G; Mann K
Biol Psychiatry; 2007 Jun; 61(11):1281-9. PubMed ID: 17239356
[TBL] [Abstract][Full Text] [Related]
44. Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: a multicenter pilot study.
Holshouser BA; Komu M; Möller HE; Zijlmans J; Kolem H; Hinshaw DB; Sonninen P; Vermathen P; Heerschap A; Masur H
Magn Reson Med; 1995 May; 33(5):589-94. PubMed ID: 7596261
[TBL] [Abstract][Full Text] [Related]
45. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
Almuqbel M; Melzer TR; Myall DJ; MacAskill MR; Pitcher TL; Livingston L; Wood KL; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26627939
[TBL] [Abstract][Full Text] [Related]
46. Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker.
Watanabe H; Fukatsu H; Katsuno M; Sugiura M; Hamada K; Okada Y; Hirayama M; Ishigaki T; Sobue G
J Neurol Neurosurg Psychiatry; 2004 Jan; 75(1):103-9. PubMed ID: 14707317
[TBL] [Abstract][Full Text] [Related]
47. Proton magnetic resonance spectroscopy of patients with parkinsonism.
Abe K; Terakawa H; Takanashi M; Watanabe Y; Tanaka H; Fujita N; Hirabuki N; Yanagihara T
Brain Res Bull; 2000 Aug; 52(6):589-95. PubMed ID: 10974501
[TBL] [Abstract][Full Text] [Related]
48. In vivo proton magnetic resonance spectroscopy of brain tumors.
Fountas KN; Kapsalaki EZ; Gotsis SD; Kapsalakis JZ; Smisson HF; Johnston KW; Robinson JS; Papadakis N
Stereotact Funct Neurosurg; 2000; 74(2):83-94. PubMed ID: 11251398
[TBL] [Abstract][Full Text] [Related]
49. Brain monoamines in progressive supranuclear palsy--comparison with idiopathic Parkinson's disease.
Hornykiewicz O; Shannak K
J Neural Transm Suppl; 1994; 42():219-27. PubMed ID: 7964689
[TBL] [Abstract][Full Text] [Related]
50. In vivo evidence for decreased scyllo-inositol levels in the supplementary motor area of patients with Progressive Supranuclear Palsy: A proton MR spectroscopy study.
Barbagallo G; Morelli M; Quattrone A; Chiriaco C; Vaccaro MG; Gullà D; Rocca F; Caracciolo M; Novellino F; Sarica A; Arabia G; Sabatini U; Quattrone A
Parkinsonism Relat Disord; 2019 May; 62():185-191. PubMed ID: 30558837
[TBL] [Abstract][Full Text] [Related]
51. Loss of striatal high affinity NGF binding sites in progressive supranuclear palsy but not in Parkinson's disease.
Villares J; Strada O; Faucheux B; Javoy-Agid F; Agid Y; Hirsch EC
Neurosci Lett; 1994 Nov; 182(1):59-62. PubMed ID: 7891888
[TBL] [Abstract][Full Text] [Related]
52. Localized proton NMR spectroscopy in the striatum of patients with idiopathic spasmodic torticollis.
Möller HE; Vollmer-Haase J; Wiedermann D; Schuierer G
Magn Reson Med; 1998 Feb; 39(2):309-12. PubMed ID: 9469715
[TBL] [Abstract][Full Text] [Related]
53. Thalamic neurometabolic alterations in tremulous Parkinson's disease: A preliminary proton MR spectroscopy study.
Barbagallo G; Arabia G; Morelli M; Nisticò R; Novellino F; Salsone M; Rocca F; Quattrone A; Caracciolo M; Sabatini U; Cherubini A; Quattrone A
Parkinsonism Relat Disord; 2017 Oct; 43():78-84. PubMed ID: 28774469
[TBL] [Abstract][Full Text] [Related]
54. Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy.
Lehéricy S; Hartmann A; Lannuzel A; Galanaud D; Delmaire C; Bienaimée MJ; Jodoin N; Roze E; Gaymard B; Vidailhet M
Brain; 2010 Aug; 133(Pt 8):2410-25. PubMed ID: 20826434
[TBL] [Abstract][Full Text] [Related]
55. Metabolite profile in the basal ganglia of children with cerebral palsy: a proton magnetic resonance spectroscopy study.
Kulak W; Sobaniec W; Smigielska-Kuzia J; Kubas B; Walecki J
Dev Med Child Neurol; 2006 Apr; 48(4):285-9. PubMed ID: 16542516
[TBL] [Abstract][Full Text] [Related]
56. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
57. Proton magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for reduced neuronal integrity in the anterior cingulate.
Tükel R; Aydın K; Ertekin E; Özyıldırım SŞ; Taravari V
Psychiatry Res; 2014 Dec; 224(3):275-80. PubMed ID: 25241042
[TBL] [Abstract][Full Text] [Related]
58. Seizure frequency and bilateral temporal abnormalities: a proton magnetic resonance spectroscopy of temporal lobe epilepsy.
Someya Y; Obata T; Suhara T; Ota Y; Ikehira H; Tanada S; Hirakawa K; Okubo Y; Sasaki Y
Seizure; 2000 Jun; 9(4):274-9. PubMed ID: 10880288
[TBL] [Abstract][Full Text] [Related]
59. Serial proton magnetic resonance spectroscopy of ischemic brain injury in humans.
Fenstermacher MJ; Narayana PA
Invest Radiol; 1990 Sep; 25(9):1034-9. PubMed ID: 2211046
[TBL] [Abstract][Full Text] [Related]
60. Differential patterns of dopamine transporter loss in the basal ganglia of progressive supranuclear palsy and Parkinson's disease: analysis with [(123)I]IPT single photon emission computed tomography.
Im JH; Chung SJ; Kim JS; Lee MC
J Neurol Sci; 2006 May; 244(1-2):103-9. PubMed ID: 16473371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
